# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Alimera Has Filed Lawsuit in the Delaware Court of Chancery to Compel ANI to Close Merger Transaction and Honor its Contractual...
Alliance Global Partners analyst James Molloy downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral.
Maxim Group analyst Naz Rahman downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Hold.
HC Wainwright & Co. analyst Yi Chen downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral and maintains $6 price...